Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2126 publications
Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).
Journal: Leukemia & lymphoma
Published: December 16, 2025
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; encorafenib for colorectal cancer, daratumumab for multiple myeloma, repotrectinib for NTRK-fusion positive solid tumors, and venetoclax for leukemia.
Journal: International journal of clinical oncology
Published: December 15, 2025
Effective front-line treatment of osteosclerotic myeloma with POEMS syndrome with daratumumab, lenalidomide and dexamethasone: a case report and literature review.
Journal: Acta clinica Belgica
Published: December 12, 2025
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.
Journal: The New England journal of medicine
Published: December 09, 2025
A new validated staging system for AL amyloidosis with Stage IIIC defining ultra-poor risk: AL International Staging System (AL-ISS).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 07, 2025
Monoclonal gammopathy of renal significance from a hematologic perspective.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
What to know about rare B-cell malignancies in 2025.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Management of autoimmune hemolytic anemia.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Sporadic Late-Onset Nemaline Myopathy Associated with Multiple Myeloma: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: December 03, 2025
Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan.
Journal: Current medical research and opinion
Published: November 26, 2025
Characteristics and Risk Analysis of COVID-19 Infection in Patients with Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation
Journal: Zhongguo shi yan xue ye xue za zhi
Published: November 14, 2025
Daratumumab-Based Regimen Significantly Induced Remission of Crystalline Light Chain Proximal Tubulopathy: A Case Report.
Journal: The American journal of case reports
Published: November 14, 2025
Last Updated: 01/07/2026